cysteine has been researched along with mesna in 38 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 11 (28.95) | 18.7374 |
| 1990's | 5 (13.16) | 18.2507 |
| 2000's | 8 (21.05) | 29.6817 |
| 2010's | 12 (31.58) | 24.3611 |
| 2020's | 2 (5.26) | 2.80 |
| Authors | Studies |
|---|---|
| Wellinger, A; Wuhrmann, K | 1 |
| Fahey, RC; Michael, BD; Vojnovic, B | 1 |
| Bertram, B; Eisenbarth, J; Rajca, A; Wiessler, M | 1 |
| Aas, P; Shaw, IC | 1 |
| Conti-Tronconi, BM; Dunn, SM; Raftery, MA | 1 |
| Schwieder, G; Wagner, T; Zink, M | 1 |
| Czarnomska, A; Czyzewska-Szafran, H; Danysz, A; Jastrzebski, Z | 1 |
| Jones, MS; Murrell, RD; Shaw, IC | 1 |
| Clutterbuck, R; Jinks, S; Millar, BC; Millar, JL | 1 |
| Burba-Anczewska, I; Danysz, A; Kłosiewicz, S; Pniewska, A; Wierzba, K | 1 |
| Gardner, ML | 1 |
| Hohorst, HJ; Jaschke, A; Voelcker, G; Wrabetz, E | 1 |
| Aarsen, G; Cats, BP; de Bree, PK; Duran, M; Fokkens, RH; Nibbering, NM; Wadman, SK | 1 |
| Cerny, T; Hartmann, B; Junker, E; Küpfer, A; Lauterburg, BH; Nguyen, T | 1 |
| Cerny, T; Junker, E; Küpfer, A; Lauterburg, BH; Stofer-Vogel, B | 1 |
| Bernstein, ML; Dubowy, RL; Fahey, RC; Newton, GL; Souid, AK | 1 |
| Bolanowska-Higdon, W; Creaven, PJ; Meropol, NJ; Murphy, M; Pendyala, L; Perez, R; Schwartz, G; Zdanowicz, J | 1 |
| Fahey, RC | 1 |
| Hausheer, F; Murphy, M; Pendyala, L; Schwartz, G; Smith, P; Zdanowicz, J | 1 |
| Booker, BM; Creaven, P; Pendyala, L; Perez, R; Smith, PF | 1 |
| Bast, A; Boven, E; Hausheer, FH; Torun, E; van der Vijgh, WJ; Verschraagen, M | 1 |
| Benesic, A; Freudinger, R; Gekle, M; Kirchhoff, A; Schwerdt, G; Wollny, B | 1 |
| Hauser, PS; Ryan, RO | 1 |
| Merkx, M; Raats, JM; Reulen, SW; van Baal, I | 1 |
| Ayala, PY; Chen, S; Chen, X; Hausheer, FH; Huang, Q; Jair, KW; Kochat, H; Parker, AR; Petluru, PN; Shanmugarajah, D | 1 |
| Helms, BA; Lempens, EH; Merkx, M | 1 |
| García-Contreras, R; Jasso-Chávez, R; Lira-Silva, E; Marín-Hernández, A; Moreno-Sánchez, R; Santiago-Martínez, MG; Zepeda-Rodríguez, A | 1 |
| Lorsch, JR; Mitchell, SF | 1 |
| Bodalia, A; Cutler, MJ; Freeman, DJ; House, AA; Urquhart, BL; Velenosi, TJ | 1 |
| Bedioui, F; Griveau, S; Liu, B; Xiao, J; Xu, H | 1 |
| Ayala, PY; Badger, J; Hausheer, FH; Jair, K; Kochat, H; Leverett, BD; Logan, C; Nienaber, VL; Parker, AR; Petluru, PN; Sridhar, V | 1 |
| Abdi, SA; Najmi, AK; Raisuddin, S | 1 |
| Li, G; Yuan, L; Zhuang, Z | 1 |
| Harvey, JA; Itzhaki, LS; Main, ERG | 1 |
| Abdi, SAH; Afjal, MA; Najmi, AK; Raisuddin, S | 1 |
| Cichos, J; Gil, W; Lisowski, M; Stefanowicz, P; Wołczański, G | 1 |
| Åsberg, A; Bastani, NE; Cox, RD; Dahl, AF; Elshorbagy, A; Olsen, T; Refsum, H; Retterstøl, K; Stolt, E; Vinknes, KJ; Zaré, HK | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
2 review(s) available for cysteine and mesna
| Article | Year |
|---|---|
Novel thiols of prokaryotes.
Topics: Cysteine; Disaccharides; Ergothioneine; Glutathione; Glycopeptides; Inositol; Mesna; Models, Chemical; Phosphothreonine; Prokaryotic Cells; Pyrazoles; Sulfhydryl Compounds | 2001 |
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
3 trial(s) available for cysteine and mesna
| Article | Year |
|---|---|
WR-2721 (amifostine) infusion in patients with Ewing's sarcoma receiving ifosfamide and cyclophosphamide with mesna: drug and thiol levels in plasma and blood cells, a Pediatric Oncology Group study.
Topics: Adolescent; Adult; Amifostine; Antineoplastic Combined Chemotherapy Protocols; Blood Cells; Bone Neoplasms; Child; Cyclophosphamide; Cysteine; Female; Humans; Ifosfamide; Infusions, Intravenous; Kinetics; Male; Mesna; Radiation-Protective Agents; Sarcoma, Ewing; Sulfhydryl Compounds; Time Factors | 1999 |
Intravenous ifosfamide/mesna is associated with depletion of plasma thiols without depletion of leukocyte glutathione.
Topics: Acetaldehyde; Antineoplastic Agents, Alkylating; Cysteine; Dose-Response Relationship, Drug; Glutathione; Homocysteine; Humans; Ifosfamide; Infusions, Intravenous; Leukocytes; Mesna; Neoplasms; Oxidation-Reduction; Protective Agents; Sulfhydryl Compounds | 2000 |
Pharmacokinetics and pharmacodynamics of mesna-mediated plasma cysteine depletion.
Topics: Antineoplastic Agents, Alkylating; Area Under Curve; Carboplatin; Chromatography, High Pressure Liquid; Cysteine; Female; Half-Life; Humans; Ifosfamide; Male; Mesna; Metabolic Clearance Rate; Middle Aged; Models, Biological; Neoplasms; Protective Agents | 2003 |
33 other study(ies) available for cysteine and mesna
| Article | Year |
|---|---|
Influence of sulfide compounds on the metabolism of Methanobacterium strain AZ.
Topics: Amino Acids; Bacteria; Cysteine; Glutathione; Mesna; Methane; Sulfides | 1977 |
The effects of counter-ion condensation and co-ion depletion upon the rates of chemical repair of poly(U) radicals by thiols.
Topics: Cysteamine; Cysteine; Electric Conductivity; Electrons; Glutathione; In Vitro Techniques; Ions; Mercaptoethanol; Mercaptoethylamines; Mesna; Particle Accelerators; Poly U; Pulse Radiolysis; Radiation-Protective Agents; Sulfhydryl Compounds | 1991 |
New mixed disulfides of L-cysteine derivatives and of glutathione with diethyldithiocarbamic acid and 2-mercaptoethanesulfonic acid.
Topics: Antineoplastic Agents; Chemical Phenomena; Chemistry; Cysteine; Disulfides; Ditiocarb; Glutathione; Magnetic Resonance Spectroscopy; Mercaptoethanol; Mesna; Molecular Structure | 1990 |
In vitro inhibition of brain glutamic acid decarboxylase by sodium 2-mercaptoethanesulphonate and endogenous thiols and its possible in vivo consequences.
Topics: Animals; Blood-Brain Barrier; Brain; Cysteine; Glutamate Decarboxylase; Glutathione; In Vitro Techniques; Male; Mercaptoethanol; Mesna; Rats; Rats, Inbred Strains; Sulfhydryl Compounds | 1989 |
Acetylcholine receptor dimers are stabilized by extracellular disulfide bonding.
Topics: Animals; Cysteine; Disulfides; Mesna; Polymers; Receptors, Cholinergic; Torpedo | 1986 |
Influence of mesna and cysteine on the systemic toxicity and therapeutic efficacy of activated cyclophosphamide.
Topics: Animals; Cyclophosphamide; Cysteine; Drug Interactions; Female; Leukemia L1210; Mercaptoethanol; Mesna; Metabolic Clearance Rate; Mice; Platelet Count; Sulfhydryl Compounds | 1987 |
The effect of sodium-2-mercaptoethane-sulphonate, N-acetylcysteine and cysteine on the uptake of cytosine arabinoside by normal and neoplastic thymus cells of mice.
Topics: Acetylcysteine; Animals; Cells, Cultured; Cysteine; Cytarabine; Female; Male; Mercaptoethanol; Mesna; Mice; Thymus Gland; Thymus Neoplasms; Tumor Cells, Cultured | 1988 |
Excretion of sodium 2-mercaptoethanesulphonate (MESNA) in the urine of volunteers after oral dosing.
Topics: Administration, Oral; Adult; Cysteine; Disulfides; Humans; Male; Mercaptoethanol; Mesna; Sulfhydryl Compounds; Urinary Bladder Diseases | 1985 |
Studies on the toxicity of cyclophosphamide in combination with mesna in vitro and in vivo.
Topics: Animals; Cricetinae; Cricetulus; Cyclophosphamide; Cysteine; Drug Therapy, Combination; Female; Humans; Male; Mercaptoethanol; Mesna; Mice; Mice, Inbred C57BL | 1983 |
The effect of sulfhydryl compounds on 5-fluorouracil toxicity and distribution.
Topics: Animals; Cysteine; Fluorouracil; Glutathione; Kinetics; Lethal Dose 50; Male; Mesna; Mice; Rats; Rats, Inbred Strains; Sulfhydryl Compounds | 1983 |
Cysteine: a potential source of error in amino acid analysis of mercaptoethane sulfonic or hydrochloric acid hydrolysates of proteins and peptides.
Topics: Amino Acids; Chemical Phenomena; Chemistry; Cysteine; Glutathione; Hydrochloric Acid; Hydrogen-Ion Concentration; Hydrolysis; Ion Exchange; Mesna; Peptides; Proline; Proteins | 1984 |
[Intracavitary chemotherapy of S 180 ascites sarcoma in mice with 4-(S-ethanol)-sulfido-cyclophosphamide in combination with protector thiols].
Topics: Animals; Cyclophosphamide; Cysteine; Drug Therapy, Combination; Female; Kinetics; Mesna; Mice; Sarcoma 180; Sulfhydryl Compounds | 1984 |
2-Mercaptoethanesulfonate-cysteine disulfide excretion following the administration of 2-mercaptoethanesulfonate--a pitfall in the diagnosis of sulfite oxidase deficiency.
Topics: Amino Acids; Cysteine; Humans; Infant, Newborn; Kidney; Liver; Mercaptoethanol; Mesna; Oxidoreductases; Oxidoreductases Acting on Sulfur Group Donors; Seizures; Sulfites | 1981 |
Depletion of total cysteine, glutathione, and homocysteine in plasma by ifosfamide/mesna therapy.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Cysteine; Female; Glutathione; Homeostasis; Homocysteine; Humans; Ifosfamide; Infusions, Intravenous; Male; Mesna; Middle Aged; Sarcoma | 1994 |
Depletion of circulating cyst(e)ine by oral and intravenous mesna.
Topics: Administration, Oral; Adult; Cysteine; Female; Glutathione; Humans; Injections, Intravenous; Male; Mesna; Time Factors | 1993 |
Modulation of plasma thiols and mixed disulfides by BNP7787 in patients receiving paclitaxel/cisplatin therapy.
Topics: Antineoplastic Combined Chemotherapy Protocols; Chromatography, High Pressure Liquid; Cisplatin; Cysteine; Disulfides; Glutathione; Half-Life; Humans; Infusions, Intravenous; Kinetics; Mesna; Neoplasms; Paclitaxel; Sulfhydryl Compounds | 2003 |
Possible (enzymatic) routes and biological sites for metabolic reduction of BNP7787, a new protector against cisplatin-induced side-effects.
Topics: Animals; Antineoplastic Agents; Cisplatin; Cysteine; Cytosol; Electrochemistry; Enzymes; Erythrocytes; Glutathione; Humans; Mesna; Protective Agents; Rats; Tissue Distribution | 2004 |
Mesna or cysteine prevents chloroacetaldehyde-induced cell death of human proximal tubule cells.
Topics: Acetaldehyde; Apoptosis; Cell Line; Cysteine; Dose-Response Relationship, Drug; Drug Antagonism; Drug Therapy, Combination; Glutathione; Humans; Kidney Tubules, Proximal; Mesna; Necrosis; Protective Agents | 2007 |
Expressed protein ligation using an N-terminal cysteine containing fragment generated in vivo from a pelB fusion protein.
Topics: Apolipoproteins; Apolipoproteins E; Cysteine; Inteins; Membrane Proteins; Mesna; Polysaccharide-Lyases; Protein Engineering; Protein Splicing; Recombinant Fusion Proteins; Serine Endopeptidases | 2007 |
Efficient, chemoselective synthesis of immunomicelles using single-domain antibodies with a C-terminal thioester.
Topics: Antibodies; Cysteine; Escherichia coli; Inteins; Mesna; Micelles; Protein Folding; Recombinant Fusion Proteins | 2009 |
Mechanistic study of BNP7787-mediated cisplatin nephroprotection: modulation of human aminopeptidase N.
Topics: Allosteric Regulation; Biocatalysis; CD13 Antigens; Cisplatin; Cysteine; Dipeptides; Glutathione; Glycine; Humans; Kidney Diseases; Kinetics; Mesna; Models, Biological; Protective Agents; Recombinant Proteins | 2011 |
Chemoselective protein and peptide immobilization on biosensor surfaces.
Topics: 3-Mercaptopropionic Acid; Aldehydes; Amino Acid Sequence; Carboxylic Acids; Cysteine; Immobilized Proteins; Ketones; Mesna; Molecular Sequence Data; Oximes; Peptides; Substrate Specificity; Succinimides; Surface Plasmon Resonance; Surface Properties; Thiazolidines | 2011 |
Cd2+ resistance mechanisms in Methanosarcina acetivorans involve the increase in the coenzyme M content and induction of biofilm synthesis.
Topics: Biofilms; Cadmium; Citrates; Cysteine; DNA, Bacterial; Drug Resistance, Bacterial; Extracellular Matrix; Malates; Mesna; Methane; Methanosarcina; Phosphates; Sulfides | 2013 |
Protein derivitization-expressed protein ligation.
Topics: Chitin; Cross-Linking Reagents; Cysteine; Esters; Inteins; Mesna; Protein Binding; Recombinant Proteins | 2014 |
Enzymatic and non-enzymatic mechanisms of dimesna metabolism.
Topics: Animals; Cell Line; Cysteine; Female; Glutathione; Homocysteine; Humans; Kidney; Liver; Mesna; Mice; Oxidation-Reduction | 2015 |
Enhanced electrochemical sensing of thiols based on cobalt phthalocyanine immobilized on nitrogen-doped graphene.
Topics: Biosensing Techniques; Cysteine; Electrochemical Techniques; Glutathione; Graphite; Indoles; Limit of Detection; Mesna; Nanocomposites; Nitrogen; Organometallic Compounds; Oxidation-Reduction; Sulfhydryl Compounds | 2015 |
Cysteine specific targeting of the functionally distinct peroxiredoxin and glutaredoxin proteins by the investigational disulfide BNP7787.
Topics: Antineoplastic Agents; Binding Sites; Crystallography, X-Ray; Cysteine; Glutaredoxins; Homeodomain Proteins; Humans; Mass Spectrometry; Mesna; Models, Molecular; Peroxiredoxins; Protein Structure, Tertiary | 2015 |
Cyclophosphamide-induced Down-Regulation of Uroplakin II in the Mouse Urinary Bladder Epithelium is Prevented by S-Allyl Cysteine.
Topics: Animals; Antineoplastic Agents; Antineoplastic Agents, Alkylating; Cyclophosphamide; Cysteine; Cystitis; Down-Regulation; Edema; Gene Expression Regulation; Hemorrhage; Mesna; Mice; Organ Size; Protective Agents; Random Allocation; RNA, Messenger; Urinary Bladder; Uroplakin II; Urothelium | 2016 |
Chemical Synthesis of Activity-Based Diubiquitin Probes.
Topics: Benzene Derivatives; Catalytic Domain; Chemistry Techniques, Synthetic; Cysteine; Deubiquitinating Enzymes; Humans; Mesna; Molecular Probes; Plasmids; Ubiquitin; Ubiquitination | 2017 |
Programmed Protein Self-Assembly Driven by Genetically Encoded Intein-Mediated Native Chemical Ligation.
Topics: Cysteine; Hydrogen-Ion Concentration; Inteins; Mesna; Nanostructures; Protein Domains; Protein Engineering; Recombinant Fusion Proteins; Temperature; Tetratricopeptide Repeat | 2018 |
S-allyl cysteine ameliorates cyclophosphamide-induced downregulation of urothelial uroplakin IIIa with a concomitant effect on expression and release of CCL11and TNF-α in mice.
Topics: Animals; Chemokine CCL11; Cyclophosphamide; Cysteine; Cystitis; Down-Regulation; Hemorrhagic Disorders; Male; Mesna; Mice; Protective Agents; Tumor Necrosis Factor-alpha; Urinary Bladder; Uroplakin III | 2018 |
Alkyl Thiocyanurates as Thioester Mimetics. Transthioesterification and Ligation Reactions with High Potential in Dynamic Covalent Chemistry.
Topics: Cysteine; Glutathione; Mesna; Peptides; Sulfhydryl Compounds | 2023 |
Cysteine-lowering treatment with mesna against obesity: Proof of concept and results from a human phase I, dose-finding study.
Topics: Animals; Clinical Trials, Phase I as Topic; Cysteine; Humans; Male; Mesna; Mice; Mice, Inbred C3H; Obesity; Overweight | 2023 |